Trials / Unknown
UnknownNCT03384888
Neurostimulation Applied to Fibromyalgia
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- Federal University of Paraíba · Academic / Other
- Sex
- Female
- Age
- 25 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
NeuroFibro is a double-blind, randomized, placebo-controlled clinical trial, using neurostimulation in women with fibromyalgia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Active tDCS | Transcranial direct current stimulation Duration: 20 minutes; Intensity: 2 mA (miliamps); Placement of the electrodes: anode over the left M1 and cathode region over the right supraorbital region. |
| DEVICE | Sham tDCS | Sham Transcranial direct current stimulation The procedure is the same as for active tDCS, but the stimulation is non-active / sham. |
Timeline
- Start date
- 2017-05-15
- Primary completion
- 2019-05-01
- Completion
- 2020-05-01
- First posted
- 2017-12-28
- Last updated
- 2019-01-23
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03384888. Inclusion in this directory is not an endorsement.